Background
Alzheimer’s disease (AD) is the most common form of dementia, age being the major risk factor. In this regard the phosphotransferase glycogen synthase kinase 3-beta (GSK3) has gained attention due to its association with axonal dysfunction and neuronal death as well as a mediation of pro-inflammatory responses.